SYN023 With Rabies Vaccine in Healthy Pediatric Subjects

Clinical trial NCT07342257 · COMPLETED

Trial details

NCT number: NCT07342257
Sponsor: Synermore Biologics (Suzhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rabies Post-exposure Prophylaxis

Start date: 2024-11-30
Primary completion: 2025-05-09
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.